의료용 외골격 시장 : 유형, 컴포넌트, 구조, 사지별 - 세계 예측(2025-2030년)

The Medical Exoskeleton Market was valued at USD 806.69 million in 2023, expected to reach USD 1,003.18 million in 2024, and is projected to grow at a CAGR of 24.84%, to USD 3,813.00 million by 2030.

The medical exoskeleton market is defined by devices designed to augment physical capabilities, primarily targeting individuals with mobility impairments due to conditions like spinal cord injuries, stroke, or cerebral palsy. These robotic frameworks deliver mechanical support and assist in rehabilitation, leading to significant improvements in patient mobility and independence. The growing necessity of medical exoskeletons is driven by the increasing prevalence of physical disabilities and the aging population worldwide. Applications extend beyond rehabilitation; they are being integrated into elderly care to reduce the risk of falls and assist in daily activities, while also being used in therapy centers to optimize patient recovery processes. Furthermore, end-use scope covers hospitals, rehabilitation centers, and home-care settings, highlighting a broad user base. Key growth factors include technological advancements in robotics, increased investments in healthcare innovation, and favorable government policies supporting assistive devices. The latest opportunities lie in developing lighter, cost-effective exoskeletons with enhanced user-friendliness, tapping into emerging markets, and collaborating with healthcare providers for better deployment strategies. However, the market faces challenges like high device costs, unfunded healthcare reimbursement policies, and stringent regulatory frameworks that slow down innovations. Barriers are compounded by limited awareness and scarcity of training for efficient exoskeleton use. To counter these challenges, research and innovation should focus on improving battery life, enhancing AI-driven mobility assistance, and making devices adaptable to diverse body types and usage scenarios. Emphasizing partnerships with insurance companies to provide coverage and developing user-engagement programs could also bolster market penetration. The market remains highly competitive yet dynamically evolving, underpinned by the need to address mobility challenges comprehensively, hence presenting ample opportunities for innovative solutions that blend affordability with advanced functionality.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Exoskeleton Market

The Medical Exoskeleton Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population and increasing number of road accidents and severe trauma injuries
  • Increasing demand for effective rehabilitation approaches and development of the exoskeleton technology
  • Growth in the insurance coverage for medical exoskeletons
• Market Restraints
  • Higher production costs and rising stringency of regulatory approvals for product launches
• Market Opportunities
  • Increasing insurance coverage for medical exoskeletons in several countries
  • Rising need for smarter and interactive solutions
  • Advancement in materials science, artificial intelligence, and robotics
• Market Challenges
  • Risks involved with exoskeletons due to vague safety guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Medical Exoskeleton Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Exoskeleton Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Exoskeleton Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Exoskeleton Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Exoskeleton Market

A detailed market share analysis in the Medical Exoskeleton Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Exoskeleton Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Exoskeleton Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Exoskeleton Market

A strategic analysis of the Medical Exoskeleton Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Exoskeleton Market, highlighting leading vendors and their innovative profiles. These include B-Temia Inc, BIONIK Inc., Bioventus, Cyberdyne Inc, Ekso Bionics Holdings Inc., Exoatlet Global S.A., Gogoa.eu, Hocoma AG, MARSI BIONICS, S.L., NextGen Healthcare, Inc., Parker Hannifin Corp, ReWalk Robotics Ltd., Rex Bionics Ltd., Suit X, and Wearable Robotics srl.

Market Segmentation & Coverage

This research report categorizes the Medical Exoskeleton Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Passive Exoskeletons and Powered Exoskeletons.
• Based on Component, market is studied across Hardware and Software. The Hardware is further studied across Actuators, Control Systems, Power Sources, and Sensors. The Actuators is further studied across Electrical, Hydraulic, Piezoelectric, and Pneumatic. The Sensors is further studied across Accelerometers, Force/Torque sensors, Gyroscopes, Microphones, Position Sensors, and Tilt Sensors.
• Based on Structure, market is studied across Rigid and Soft.
• Based on Extremity, market is studied across Full Body, Lower Extremity Medical Exoskeletons, and Upper Extremity Medical Exoskeletons.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population and increasing number of road accidents and severe trauma injuries
    • 5.1.1.2. Increasing demand for effective rehabilitation approaches and development of the exoskeleton technology
    • 5.1.1.3. Growth in the insurance coverage for medical exoskeletons
  • 5.1.2. Restraints
    • 5.1.2.1. Higher production costs and rising stringency of regulatory approvals for product launches
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing insurance coverage for medical exoskeletons in several countries
    • 5.1.3.2. Rising need for smarter and interactive solutions
    • 5.1.3.3. Advancement in materials science, artificial intelligence, and robotics
  • 5.1.4. Challenges
    • 5.1.4.1. Risks involved with exoskeletons due to vague safety guidelines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Medical Exoskeleton Market, by Type

• 6.1. Introduction
• 6.2. Passive Exoskeletons
• 6.3. Powered Exoskeletons

7. Medical Exoskeleton Market, by Component

• 7.1. Introduction
• 7.2. Hardware
  • 7.2.1. Actuators
    • 7.2.1.1. Electrical
    • 7.2.1.2. Hydraulic
    • 7.2.1.3. Piezoelectric
    • 7.2.1.4. Pneumatic
  • 7.2.2. Control Systems
  • 7.2.3. Power Sources
  • 7.2.4. Sensors
    • 7.2.4.1. Accelerometers
    • 7.2.4.2. Force/Torque sensors
    • 7.2.4.3. Gyroscopes
    • 7.2.4.4. Microphones
    • 7.2.4.5. Position Sensors
    • 7.2.4.6. Tilt Sensors
• 7.3. Software

8. Medical Exoskeleton Market, by Structure

• 8.1. Introduction
• 8.2. Rigid
• 8.3. Soft

9. Medical Exoskeleton Market, by Extremity

• 9.1. Introduction
• 9.2. Full Body
• 9.3. Lower Extremity Medical Exoskeletons
• 9.4. Upper Extremity Medical Exoskeletons

10. Americas Medical Exoskeleton Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Medical Exoskeleton Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Medical Exoskeleton Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B-Temia Inc
• 2. BIONIK Inc.
• 3. Bioventus
• 4. Cyberdyne Inc
• 5. Ekso Bionics Holdings Inc.
• 6. Exoatlet Global S.A.
• 7. Gogoa.eu
• 8. Hocoma AG
• 9. MARSI BIONICS, S.L.
• 10. NextGen Healthcare, Inc.
• 11. Parker Hannifin Corp
• 12. ReWalk Robotics Ltd.
• 13. Rex Bionics Ltd.
• 14. Suit X
• 15. Wearable Robotics srl